This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignees: Imperial College Innovations Limited, Myricx Pharma Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 173 
1 out of 2 Years Active: 2026
Title: The Innovations of Roberto Solari
Introduction
Roberto Solari is a notable inventor based in London, GB. He has made significant contributions to the field of therapy through his innovative research and development. His work has led to the creation of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Roberto Solari holds a patent for "Cytotoxic Imidazo[1,2-a]pyridine Compounds and Their Use in Therapy." This patent highlights his focus on developing compounds that can be utilized in therapeutic applications, demonstrating his commitment to improving healthcare outcomes.
Career Highlights
Throughout his career, Solari has worked with esteemed organizations such as Imperial College Innovations Limited and Myricx Pharma Limited. His experience in these companies has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Robin Carr and Andrew Simon Bell. Their collaboration has likely enriched the research environment and fostered innovative ideas in their respective projects.
Conclusion
Roberto Solari's contributions to the field of therapy through his patent and collaborations with esteemed organizations and individuals underscore his role as a significant inventor. His work continues to inspire advancements in medical science and therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile